A study reveals the biological changes in breast cancer between the primary tumor and metastases

by Fundació Clínic per a la Recerca Biomèdica

A study published in the journal Cancer Research underscores the importance of the molecular characterization of the metastases in breast cancer. Researchers have described, for the first time, that t...

Read more

Bioinformatics brings to light new combinations of drugs to fight breast cancer

by Instituto de Investigación Biomédica ( IRB Barcelona )

A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to bre...

Read more

Hospital Clínic will implement a new genomic test to predict response to treatment in breast cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers from Hospital Clínic and IDIBAPS lead an international study in which they have developed a genomic test to predict the response to chemotherapy in breast cancer. Hospital Clínic of Barc...

Read more

La Masia and the AECC promoting a solidarity oil for breast cancer research

by Vall d’Hebron

The Spanish Association Against Cancer (AECC) and La Masía have presented today the initiative "Aceite de Oliva Solidario" (Solidarity Olive Oil). The goal of the challenge – which starts today and...

Read more

'Live' breast cancer biobank to accelerate more precise testing of experimental anti-cancer medicines

by Vall d’Hebron

High-throughput mass screening platform to spur drug development in breast cancer by testing response to over 100 anti-cancer agents as monotherapy or in combination. Response to therapy validated in ...

Read more

Therapeutic RANK inhibition reduces breast cancer recurrence

by Institut d'Investigació Biomèdica de Bellvitge

Researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL), led by Dr. Eva Gonzalez-Suarez, have shown that pharmacological and genetic inhibition of signaling pathway RANK / RANKL lea...

Read more

Exploring mechanisms of resistance against ER+ and BRCA1 breast cancer therapies

by Vall d’Hebron

Various research lines led by VHIO aim at better deciphering how tumor cells acquire resistance to anticancer agents including palbociclib and treatments inducing DNA damage. The expression of partial...

Read more

The importance of keeping silent... in breast cancer cells

by Centre for Genomic Regulation

Researchers at the Centre for Genomic Regulation describe a repression mechanism active in hormone-dependent breast cancer cells for the first time. The repression complex of these cells silences gene...

Read more

First molecular test that enables fine-tuned prognosis and prediction in advanced breast cancer

by Fundació Clínic per a la Recerca Biomèdica

Findings show that the genomic classification of tumors — the molecular subtyping of primary tumors, can predict the evolution of patients from the onset of metastasis and that this cancer intrinsic...

Read more

Researchers discover that breast cancer tumour growth is dependent on lipid availability

by Instituto de Investigación Biomédica ( IRB Barcelona )

In an article published in Nature Communications, scientists at IRB Barcelona reveal that breast cancer cells require fatty acids from the extracellular environment in order to continue proliferating....

Read more

Myriad myRisk® Hereditary Cancer: expanding genetic testing for breast cancer patients

by Myriad Genetics Iberia

Prospective Clinical Study Showed the myRisk Test Identified 70 Percent More Deleterious Mutations than BRCA Testing Alone with 42 Percent of These in Women Over Age 45.

Read more

A genetic test at the time of diagnosis, useful for predicting treatment response in breast cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers have shown that the biology identified with genomic data is the most significant predictor of treatment response and survival beyond the 4-5 variables that are currently used in clinical p...

Read more
Subscribe to Directory
Write an Article

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Closing in on advanced prostate cancer

by Instituto de Investigación Biomédica ( IRB Barcelona )

Xavier Salvatella, ICREA researcher at IRB Barcelona, ​​proposes a...

Photos Stream